COMMUNIQUÉS West-GlobeNewswire

-
Disclosure of received notifications
16/09/2019 -
The Nomination Committee's proposal regarding Board of Directors and auditor of Oasmia Pharmaceutical AB for AGM 2019
15/09/2019 -
Akesis Previews Next-Generation Galaxy SRS and New LINAC Platform at ASTRO
15/09/2019 -
BioRestorative Therapies Comments on Recent Promotional Activity
14/09/2019 -
Radius Health to Present Data on Abaloparatide at ASBMR 2019 Annual Meeting
14/09/2019 -
Medtronic Named a Leading Sustainability Company
13/09/2019 -
Golden Leaf Holdings Ltd. Announces New Interim CFO
13/09/2019 -
Sienna Announces September Dividend
13/09/2019 -
Presentation och videointervju med Arcomas VD från Bolagsdagen den 12:e september.
13/09/2019 -
The Eye Institute of Utah Among First in State to Offer PanOptix Trifocal IOL and the RxSight Light Adjustable Lens System
13/09/2019 -
Profound Medical Announces Pricing of Offerings
13/09/2019 -
Genmab Announces Positive Topline Results in Phase III Study of Daratumumab in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma
13/09/2019 -
National Patient Survey Highlights Healthcare Challenges for the 1 in 4 Americans Living with Rheumatic Disease
13/09/2019 -
Intrommune Therapeutics Receives Support from Allergy & Asthma Network
13/09/2019 -
Detailed Results from the Phase III ASCLEPIOS I & II Studies of Ofatumumab in Patients with Relapsing Multiple Sclerosis Presented at ECTRIMS
13/09/2019 -
Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program
13/09/2019 -
NimbleRx Officially Introduces Itself as First Delivery Service Designed for Independent and Local Pharmacies
13/09/2019 -
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
13/09/2019 -
Weight Watchers International, Inc. to Change its Legal Name to WW International, Inc. Following Rebranding Last Year
13/09/2019
Pages